Literature DB >> 23550006

Kisspeptin antagonists.

Antonia Kathryn Roseweir1, Robert P Millar.   

Abstract

Kisspeptin is now known to be an important regulator of the hypothalamic--pituitary-gonadal axis and is the target of a range of regulators, such as steroid hormone feedback, nutritional and metabolic regulation. Kisspeptin binds to its cognate receptor, KISS1R (also called GPR54), on GnRH neurons and stimulates their activity, which in turn provides an obligatory signal for GnRH secretion-thus gating down-stream events supporting reproduction. The development of peripherally active kisspeptin antagonists could offer a unique therapeutic agent for treating hormone-dependent disorders of reproduction, including precocious puberty, endometriosis, and metastatic prostate cancer. The following chapter discusses the advances made in the search for both peptide and small molecule kisspeptin antagonists and their use in delineating the role of kisspeptin within the reproductive system. To date, four peptide antagonists and one small molecule antagonist have been designed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550006     DOI: 10.1007/978-1-4614-6199-9_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Surge-Like Luteinising Hormone Secretion Induced by Retrochiasmatic Area NK3R Activation is Mediated Primarily by Arcuate Kisspeptin Neurones in the Ewe.

Authors:  P Grachev; K L Porter; L M Coolen; R B McCosh; J M Connors; S M Hileman; M N Lehman; R L Goodman
Journal:  J Neuroendocrinol       Date:  2016-06       Impact factor: 3.627

Review 2.  Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction.

Authors:  Kai-Lun Hu; Zimiao Chen; Xiaoxue Li; Enci Cai; Haiyan Yang; Yi Chen; Congying Wang; Liping Ju; Wenhai Deng; Liangshan Mu
Journal:  Reprod Biol Endocrinol       Date:  2022-05-23       Impact factor: 4.982

Review 3.  Kisspeptin and neurokinin B analogs use in gynecological endocrinology: where do we stand?

Authors:  A Szeliga; A Podfigurna; G Bala; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2019-12-14       Impact factor: 4.256

4.  In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation.

Authors:  C H J Albers-Wolthers; J de Gier; M Walen; P J S van Kooten; C B Lambalk; P A J Leegwater; B A J Roelen; A C Schaefers-Okkens; V P M G Rutten; R P M Millar; H S Kooistra
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.